Anna W. Lee

About Anna W. Lee

Drug development scientist committed to bringing meaningful medicines to patients. Critical thinker, with strong analytical skills, demonstrated ability to provide solutions to complex problems. Over 30 years of research experience, including 14+ years in pharma/biotech in preclinical, translational, and clinical research. Broad familiarity with diverse CNS indications, including rare/ultra-rare genetic diseases, neuromuscular, and cardiovascular-renal diseases. Clinical experience with phase 1, 2, and 3 trials, with small molecules, cell therapies, and gene therapies. Extensive managerial and project leadership experience in a global matrix environment. Proven track record of achievements, executing and delivering critical milestones in a timely manner, developing relationships across all levels and functions, managing collaborations, and mentoring and developing talent.

Experience

1. Senior Clinical Development Director

   Novartis

   Jun 2021 — Present · East Hanover, NJ, US

   Global clinical lead for phase 3 study in spinal muscular atrophy

Education

• Dalhousie University

  PhD, Psychology & Neuroscience

• Dalhousie University

  Master’s Degree, Psychology

• University of Toronto

  Bachelor of Science (BSc), Psychology

Skills

• Pharmaceutical Industry
• Neuroendocrinology
• Neuropharmacology
• Life Sciences
• Statistics
• Electrophysiology
• Writing
• Translational Research
• Neuroanatomy
• Molecular Biology
• Drug Discovery
• Neuroinflammation
• Major Depressive Disorder
• Reproductive Endocrinology
• Physiology
• Cell Biology
• Elisa
• In Vivo
• Histology
• CRO Management
• Pcr
• Data Analysis
• Animal Models
• Immunofluorescence
• Spss
• CRO
• Rna Isolation
• Biomarkers
• Neuroscience
• Western Blotting
• Biobanking
• Assay Development
• Reproductive Biology
• Inflammation Models
• Cell Culture
• Behavioral Neuroscience
• Cell
• In Vitro
• Genomics
• Immunohistochemistry